Synchrony Financial (SYF) is back in focus after its Q4 2025 earnings, where net income of $751 million and record purchase volume above $49 billion met a softer revenue line and cautious 2026 commentary.

The Q4 release and cautious 2026 commentary have been followed by a sharp pullback, with a 30 day share price return of a 14.2% decline and a year to date share price return matching that move. At the same time, the 1 year total shareholder return of 7.16% and 5 year total shareholder return of 117.05% show a much stronger longer run picture, suggesting that recent weakness may reflect changing views on risk and growth rather than the entire story on Synchrony Financial.

If this kind of volatility has you thinking about what else is out there, it could be a good time to look at fast growing stocks with high insider ownership as a source of new ideas.

With Synchrony posting solid earnings, record purchase volumes and a fresh US$2.5b buyback while the stock slides double digits in a month, you have to ask: is this a genuine value opening, or is the market already discounting future growth?

Most Popular Narrative: 17.7% Undervalued

The most followed narrative currently points to a fair value of about $88.22 per share, compared with Synchrony Financial's last close at $72.63, and anchors that view in long run earnings power and partnerships rather than short term share price swings.

The company's expansion in high growth verticals like health, wellness, and pet financing where it is resuming growth after recent credit tightening broadens the consumer base and diversifies revenue streams, contributing to more sustainable earnings growth and risk mitigation over the long run.

Want to see what is really backing that price gap? The narrative leans on richer revenue expectations, tighter margins, and a future earnings multiple that is not conservative.

Result: Fair Value of $88.22 (UNDERVALUED)

However, you still need to weigh the risk that key retail partners change terms or that credit conditions shift. Either of these developments could quickly challenge this undervaluation story.

Build Your Own Synchrony Financial Narrative

If you do not fully agree with this view or you prefer to work from your own research, you can build a custom thesis in just a few minutes with Do it your way.

A great starting point for your Synchrony Financial research is our analysis highlighting 6 key rewards and 3 important warning signs that could impact your investment decision.

Looking for more investment ideas?

If Synchrony has you thinking differently about risk and return, do not stop here. Broaden your watchlist now so you are not late to the next idea.

• Spot potential value opportunities early by scanning these 875 undervalued stocks based on cash flows built around cash flow focused metrics.
• Lean into long term themes by checking out these 24 AI penny stocks that tie artificial intelligence into real business models.
• Add income angles to your research with these 12 dividend stocks with yields > 3% that filter for yields above 3%.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.